Ionis Pharma (IONS) Misses Q3 EPS by 2c

Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $110.9 million versus the consensus estimate of $113.09 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Renasant Corp. (RNST) Tops Q1 EPS by 3c
• Bank of N.T. Butterfield & Son (NTB) Tops Q1 EPS by 20c